Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1997
Neurotoxicity of CI-980, a novel mitotic inhibitor
C A Meyers, A P Kudelka, C A Conrad, et al.
Acta Psychiatrica Scandinavica
|
December 1, 1986
Immigration and major affective disorder
W Grove, P J Clayton, J Endicott, et al.
American Journal of Clinical Oncology
|
December 10, 1997
Phase II trial of intravenous CI-980 (NSC 370147) in patients with metastatic colorectal carcinoma. Model for prospective evaluation of neurotoxicity
R Pazdur, C Meyers, E Diaz-Canton, et al.
Investigational New Drugs
|
November 1, 1990
3-Deazaguanine: report of a phase I trial and drug-related cardiac toxicity
K Margolin, J Doroshow, L Leong, et al.
Cancer Chemotherapy and Pharmacology
|
November 7, 1999
A phase II trial of CI-958 in patients with hormone-refractory prostate cancer
P V Woolley, F S Freiha, D C Smith, et al.
Neuromodulation : Journal of the International Neuromodulation Society
|
December 14, 2011
Continuous Intrathecal Infusion of Ziconotide for Treatment of Chronic Malignant and Nonmalignant Pain Over 12 Months: A Prospective, Open-label Study
David J Ellis, Sanjeeva Dissanayake, Dawn McGuire, et al.
Cancer Research
|
November 15, 1988
Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921)
J R Hardy, V J Harvey, J W Paxton, et al.
Journal of Personality Disorders
|
May 6, 1999
The Iowa Personality Disorder Screen: development and preliminary validation of a brief screening interview
D R Langbehn, B M Pfohl, S Reynolds, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2006
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study
D A Richards, K A Boehm, D M Waterhouse, et al.
Scientific Reports
|
November 15, 2022
Low net carbonate accretion characterizes Florida's coral reef
John T Morris, Ian C Enochs, Nicole Besemer, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1997
Neurotoxicity of CI-980, a novel mitotic inhibitor
C A Meyers, A P Kudelka, C A Conrad, et al.
Acta Psychiatrica Scandinavica
|
December 1, 1986
Immigration and major affective disorder
W Grove, P J Clayton, J Endicott, et al.
American Journal of Clinical Oncology
|
December 10, 1997
Phase II trial of intravenous CI-980 (NSC 370147) in patients with metastatic colorectal carcinoma. Model for prospective evaluation of neurotoxicity
R Pazdur, C Meyers, E Diaz-Canton, et al.
Investigational New Drugs
|
November 1, 1990
3-Deazaguanine: report of a phase I trial and drug-related cardiac toxicity
K Margolin, J Doroshow, L Leong, et al.
Cancer Chemotherapy and Pharmacology
|
November 7, 1999
A phase II trial of CI-958 in patients with hormone-refractory prostate cancer
P V Woolley, F S Freiha, D C Smith, et al.
Neuromodulation : Journal of the International Neuromodulation Society
|
December 14, 2011
Continuous Intrathecal Infusion of Ziconotide for Treatment of Chronic Malignant and Nonmalignant Pain Over 12 Months: A Prospective, Open-label Study
David J Ellis, Sanjeeva Dissanayake, Dawn McGuire, et al.
Cancer Research
|
November 15, 1988
Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921)
J R Hardy, V J Harvey, J W Paxton, et al.
Journal of Personality Disorders
|
May 6, 1999
The Iowa Personality Disorder Screen: development and preliminary validation of a brief screening interview
D R Langbehn, B M Pfohl, S Reynolds, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2006
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study
D A Richards, K A Boehm, D M Waterhouse, et al.
Scientific Reports
|
November 15, 2022
Low net carbonate accretion characterizes Florida's coral reef
John T Morris, Ian C Enochs, Nicole Besemer, et al.
Page
of 4